{iframe}http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-15-012.html{/iframe}
Peripheral Blood Biomarkers of Chronic Traumatic Brain Injury in Human Subjects – SBIR Direct Phase II (R44) – Aug 29, 2014
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.